Trials / Recruiting
RecruitingNCT06919913
The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether probiotics in addition to standard of care (SOC) can improve immunological markers following treatment for prosthetic joint infection (PJI). The study aims to determine whether probiotics in addition to SOC decrease immunological markers following treatment for PJI, improve medical and surgical complications and mortality in patients with PJI, and lead to improved gastrointestinal (GI)-specific patient reported outcomes measures (PROMs) in patients with PJI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Culturelle Digestive Daily Probiotic Capsule | Each capsule contains 10 billion colony-forming units (CFU) of Lactobacillus rhamnosus GG. Subjects will self-administer 1 oral capsule daily for 6 weeks post operatively. |
Timeline
- Start date
- 2025-07-12
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2025-04-09
- Last updated
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06919913. Inclusion in this directory is not an endorsement.